Monoclonal antibodies in cancer therapy. 1989

H Mellstedt
Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

H Mellstedt
July 2020, Antibodies (Basel, Switzerland),
H Mellstedt
September 2004, Current medicinal chemistry. Anti-cancer agents,
H Mellstedt
January 1996, Springer seminars in immunopathology,
H Mellstedt
February 1989, Pathologie-biologie,
H Mellstedt
September 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Mellstedt
October 1993, Current opinion in immunology,
H Mellstedt
April 1985, Deutsche medizinische Wochenschrift (1946),
H Mellstedt
January 2012, Cancer immunity,
H Mellstedt
January 1988, Israel journal of medical sciences,
H Mellstedt
January 2013, Oncoimmunology,
Copied contents to your clipboard!